<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font6" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font7" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font8" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font9" size="7" family="Helvetica" color="#000000"/>
	<fontspec id="font10" size="7" family="VSLHDX+Helvetica,Bold" color="#000000"/>
	<fontspec id="font11" size="7" family="VSLHDX+Helvetica,Bold" color="#000000"/>
	<fontspec id="font12" size="6" family="Helvetica" color="#000000"/>
<text top="41" left="55" width="179" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Emerging Themes in Epidemiology 2005, 2 :9<i>Emerging Themes in Epidemiology</i></text>
<text top="41" left="373" width="181" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.biomedcentral.com/1742-7622/2/9</text>
<text top="756" left="498" width="56" height="10" font="font1" id="p1_t3" reading_order_no="128" segment_no="12" tag_type="text">Page 10 of 18<b>2</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="129" segment_no="13" tag_type="text">(page number not for citation purposes)</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="53" segment_no="9" tag_type="text">illustrates the urgent need for cheap and reliable second-</text>
<text top="463" left="55" width="230" height="9" font="font4" id="p1_t6" reading_order_no="54" segment_no="9" tag_type="text">line treatment options to be available for ART roll-out.</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="55" segment_no="10" tag_type="text">Despite our view that Blower et al are over-optimistic [5],<i>(page number not for citation purposes)</i></text>
<text top="498" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="56" segment_no="10" tag_type="text">Gray et al's assumptions of the effects of ART may simi-</text>
<text top="510" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="57" segment_no="10" tag_type="text">larly be over-pessimistic [2]. The authors assume that ART</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="58" segment_no="10" tag_type="text">leads to an average proportional reduction in HIV log viral<a href=""> [5],</a></text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="59" segment_no="10" tag_type="text">load of between 26.8% and 43.6%, based on data from</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="60" segment_no="10" tag_type="text">the Women's Interagency HIV Study (WIHS) [48] and the<a href="">ssimistic [2]. The authors assume</a> that ART</text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="61" segment_no="10" tag_type="text">John Hopkins Clinic [49] respectively. However, other</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="62" segment_no="10" tag_type="text">studies distinguish between patients who respond to a</text>
<text top="580" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="63" segment_no="10" tag_type="text">regimen (who typically experience reduction in viral load<a href="">IHS) [48] and the</a></text>
<text top="592" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="64" segment_no="10" tag_type="text">to undetectable levels (&lt;50 copies/ml)), those who do not<a href="">ins Clinic [49] respec</a>tively. However, other</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="65" segment_no="10" tag_type="text">respond and those who subsequently experience treat-</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="66" segment_no="10" tag_type="text">ment failure (viral rebound). With these distinctions, an</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="67" segment_no="10" tag_type="text">individual responding successfully to ART will have a far</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="68" segment_no="10" tag_type="text">greater reduction in viral load than Gray et al assume. Fur-</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="69" segment_no="10" tag_type="text">thermore, the proportion reduction was the value</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="70" segment_no="10" tag_type="text">recorded one month and three months after treatment ini-</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="71" segment_no="10" tag_type="text">tiation for the WIHS and John Hopkins Clinic patients,</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="72" segment_no="10" tag_type="text">respectively. It can take much longer than this for com-</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t25" reading_order_no="73" segment_no="10" tag_type="text">plete reduction of viral load, often to undetectable limits</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="74" segment_no="10" tag_type="text">[50] (models generally do not explicitly account for a</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="75" segment_no="10" tag_type="text">delay between treatment initiation and effect, but it can be</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t28" reading_order_no="76" segment_no="2" tag_type="text">assumed that this is implicitly accounted for in the treat-</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t29" reading_order_no="77" segment_no="2" tag_type="text">ment uptake rate). Gray et al also included the possibility<a href="">50] (mode</a>ls generally do not explicitly account for a</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t30" reading_order_no="78" segment_no="2" tag_type="text">of behavioural disinhibition; the average number of part-</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t31" reading_order_no="79" segment_no="2" tag_type="text">ners for those on treatment was increased by 50% or</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t32" reading_order_no="80" segment_no="2" tag_type="text">100%. Again, the values appear pessimistic and were</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t33" reading_order_no="81" segment_no="2" tag_type="text">essentially chosen arbitrarily, probably in order to com-</text>
<text top="157" left="313" width="119" height="9" font="font4" id="p1_t34" reading_order_no="82" segment_no="2" tag_type="text">plement other models [4,5].</text>
<text top="181" left="313" width="142" height="9" font="font5" id="p1_t35" reading_order_no="83" segment_no="4" tag_type="title">Emergence of ART drug resistance</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t36" reading_order_no="84" segment_no="5" tag_type="text">Many models of ART have concentrated on predicting the</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t37" reading_order_no="85" segment_no="5" tag_type="text">emergence and spread of ART drug resistance, which has<a href=""> models [4,5].</a></text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t38" reading_order_no="86" segment_no="5" tag_type="text">been of concern [51-54]. Once again it is very difficult to<i><b>Emergence of ART drug resistance</b></i></text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t39" reading_order_no="87" segment_no="5" tag_type="text">make such predictions, as the spread of drug-resistant</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t40" reading_order_no="88" segment_no="5" tag_type="text">virus is highly dependent on the replicative fitness of the</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t41" reading_order_no="89" segment_no="5" tag_type="text">resistant strains that evolve and their ability to superinfect<a href="">n [51-54]. O</a>nce again it is very difficult to</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t42" reading_order_no="90" segment_no="5" tag_type="text">individuals infected with wild-type strains (i.e. to co-</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t43" reading_order_no="91" segment_no="5" tag_type="text">infect someone already infected with wild-type virus, and</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t44" reading_order_no="92" segment_no="5" tag_type="text">successfully replicate). Superinfection is perhaps only</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t45" reading_order_no="93" segment_no="5" tag_type="text">likely in the successfully treated individual, where sup-</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t46" reading_order_no="94" segment_no="5" tag_type="text">pression of viral load allows the target cell population to</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t47" reading_order_no="95" segment_no="5" tag_type="text">recover, hence increasing the chance of successful replica-</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t48" reading_order_no="96" segment_no="5" tag_type="text">tion and establishment of a new strain. In the untreated</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t49" reading_order_no="97" segment_no="5" tag_type="text">individual, it is unlikely that low frequency resistant virus,</text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t50" reading_order_no="98" segment_no="5" tag_type="text">typically less fecund than wild type in this environment,</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t51" reading_order_no="99" segment_no="5" tag_type="text">would be able to compete against the established viral</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t52" reading_order_no="100" segment_no="5" tag_type="text">population sufficiently successfully to allow long-term</text>
<text top="392" left="313" width="141" height="9" font="font4" id="p1_t53" reading_order_no="101" segment_no="5" tag_type="text">persistence of the invading strain.</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t54" reading_order_no="102" segment_no="8" tag_type="text">In a context where ART use is common in core groups, the</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t55" reading_order_no="103" segment_no="8" tag_type="text">possibility of superinfection of those on ART means that</text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="104" segment_no="8" tag_type="text">the likely maximum rate of spread of resistance epidemics</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="105" segment_no="8" tag_type="text">may be similar to the speed of the initial HIV epidemic.</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="106" segment_no="8" tag_type="text">HIV co-infection with different wild-type viruses [55,56],</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="107" segment_no="8" tag_type="text">and by wild-type strains re-infecting patients harbouring</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="108" segment_no="8" tag_type="text">drug-resistant viruses after a short period of treatment</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="109" segment_no="8" tag_type="text">interruption [57,58], have both been documented.<a href="">[55,56</a>],</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="110" segment_no="8" tag_type="text">Chakraborty et al postulate that it is possible for patients</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="111" segment_no="8" tag_type="text">infected with wild type HIV-1 isolates and under success-</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="112" segment_no="8" tag_type="text">ful ART to become exposed to drug-resistant strains that<a href="">[57,58</a>], have both been documented.</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="113" segment_no="8" tag_type="text">would have significant selective advantage, leading them</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="114" segment_no="8" tag_type="text">to outcompete the original wild-type strain and instigate</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="115" segment_no="8" tag_type="text">treatment failure [59]. They concede that the probability</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="116" segment_no="8" tag_type="text">of an individual undergoing successful treatment of a</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="117" segment_no="8" tag_type="text">wild-type strain being exposed to a drug-resistant strain is</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="118" segment_no="8" tag_type="text">low, but the large-scale roll-out of ART in high prevalence,<a href="">ent failure [59</a>]. They concede that the probability</text>
<text top="615" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="119" segment_no="8" tag_type="text">resource-poor settings may increase this probability</text>
<text top="627" left="313" width="56" height="9" font="font4" id="p1_t72" reading_order_no="120" segment_no="8" tag_type="text">substantially.</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="121" segment_no="11" tag_type="text">The rate at which drug resistance evolves within the indi-</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="122" segment_no="11" tag_type="text">vidual is likely to become higher in resource-poor settings</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="123" segment_no="11" tag_type="text">than industrialised countries; even though there are</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="124" segment_no="11" tag_type="text">reports of patient adherence being no lower than in the</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="125" segment_no="11" tag_type="text">West [60], potential interruptions in supply due to trans-</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="126" segment_no="11" tag_type="text">port problems and a lack of sophisticated laboratory</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t79" reading_order_no="127" segment_no="11" tag_type="text">monitoring systems will limit the success of any ART</text>
<text top="254" left="55" width="225" height="9" font="font6" id="p1_t80" reading_order_no="39" segment_no="6" tag_type="title">Predictions of the impact of ART by stage of infection at<a href="">60], pote</a>ntial interruptions in supply due to trans-</text>
<text top="254" left="55" width="108" height="9" font="font6" id="p1_t81" reading_order_no="38" segment_no="6" tag_type="title">which treatment is initiated</text>
<text top="254" left="55" width="37" height="9" font="font7" id="p1_t82" reading_order_no="37" segment_no="6" tag_type="title">Figure 2</text>
<text top="264" left="55" width="229" height="9" font="font7" id="p1_t83" reading_order_no="40" segment_no="7" tag_type="text">Predictions of the impact of ART by stage of infec-</text>
<text top="275" left="55" width="237" height="9" font="font7" id="p1_t84" reading_order_no="41" segment_no="7" tag_type="text">tion at which treatment is initiated . Predictions of the</text>
<text top="286" left="55" width="241" height="9" font="font8" id="p1_t85" reading_order_no="42" segment_no="7" tag_type="text">impact of the introduction of ART in terms of HIV incidence,<b>Figure 2</b></text>
<text top="297" left="55" width="227" height="9" font="font8" id="p1_t86" reading_order_no="43" segment_no="7" tag_type="text">by stage of infection at which treatment is initiated (for a<b>Predictions of the impact of ART by stage of infec-</b></text>
<text top="307" left="55" width="238" height="9" font="font8" id="p1_t87" reading_order_no="44" segment_no="7" tag_type="text">brief description of the four stage infection model used, see<b>tion at which treatment is initiated</b></text>
<text top="318" left="55" width="227" height="9" font="font8" id="p1_t88" reading_order_no="45" segment_no="7" tag_type="text">Endnote). Scenario A – No treatment. Scenario B – ART</text>
<text top="329" left="55" width="231" height="9" font="font8" id="p1_t89" reading_order_no="46" segment_no="7" tag_type="text">uptake: AIDS patients only (after a mean of 1 month). Sce-</text>
<text top="340" left="55" width="237" height="9" font="font8" id="p1_t90" reading_order_no="47" segment_no="7" tag_type="text">nario C – ART uptake: AIDS patients (after mean 1 month)</text>
<text top="350" left="55" width="225" height="9" font="font8" id="p1_t91" reading_order_no="48" segment_no="7" tag_type="text">and pre-AIDS (after mean 6 months). Scenario D – ART</text>
<text top="361" left="55" width="232" height="9" font="font8" id="p1_t92" reading_order_no="49" segment_no="7" tag_type="text">uptake: AIDS patients (after mean 1 month) and pre-AIDS</text>
<text top="372" left="55" width="230" height="9" font="font8" id="p1_t93" reading_order_no="50" segment_no="7" tag_type="text">(after mean 6 months) and incubation stage (after mean 4</text>
<text top="383" left="55" width="241" height="9" font="font8" id="p1_t94" reading_order_no="51" segment_no="7" tag_type="text">years). Scenario E – ART uptake: all four stages, after mean 1</text>
<text top="394" left="55" width="28" height="9" font="font8" id="p1_t95" reading_order_no="52" segment_no="7" tag_type="text">month.</text>
<text top="207" left="106" width="4" height="7" font="font9" id="p1_t96" reading_order_no="24" segment_no="3" tag_type="figure">0</text>
<text top="188" left="87" width="23" height="7" font="font9" id="p1_t97" reading_order_no="23" segment_no="3" tag_type="figure">20,000</text>
<text top="169" left="87" width="23" height="7" font="font9" id="p1_t98" reading_order_no="22" segment_no="3" tag_type="figure">40,000</text>
<text top="150" left="87" width="23" height="7" font="font9" id="p1_t99" reading_order_no="21" segment_no="3" tag_type="figure">60,000</text>
<text top="131" left="87" width="23" height="7" font="font9" id="p1_t100" reading_order_no="20" segment_no="3" tag_type="figure">80,000</text>
<text top="111" left="82" width="28" height="7" font="font9" id="p1_t101" reading_order_no="19" segment_no="3" tag_type="figure">100,000</text>
<text top="92" left="82" width="28" height="7" font="font9" id="p1_t102" reading_order_no="18" segment_no="3" tag_type="figure">120,000</text>
<text top="218" left="114" width="4" height="7" font="font9" id="p1_t103" reading_order_no="25" segment_no="3" tag_type="figure">0</text>
<text top="218" left="154" width="8" height="7" font="font9" id="p1_t104" reading_order_no="26" segment_no="3" tag_type="figure">20</text>
<text top="218" left="197" width="8" height="7" font="font9" id="p1_t105" reading_order_no="27" segment_no="3" tag_type="figure">40</text>
<text top="218" left="239" width="8" height="7" font="font9" id="p1_t106" reading_order_no="28" segment_no="3" tag_type="figure">60</text>
<text top="218" left="282" width="8" height="7" font="font9" id="p1_t107" reading_order_no="29" segment_no="3" tag_type="figure">80</text>
<text top="230" left="179" width="45" height="9" font="font10" id="p1_t108" reading_order_no="36" segment_no="3" tag_type="figure">Time (years)</text>
<text top="204" left="69" width="0" height="9" font="font11" id="p1_t109" reading_order_no="9" segment_no="3" tag_type="figure">HI</text>
<text top="196" left="69" width="0" height="9" font="font11" id="p1_t110" reading_order_no="8" segment_no="3" tag_type="figure">V</text>
<text top="189" left="69" width="0" height="9" font="font11" id="p1_t111" reading_order_no="7" segment_no="3" tag_type="figure">inci</text>
<text top="171" left="69" width="0" height="14" font="font11" id="p1_t112" reading_order_no="6" segment_no="3" tag_type="figure">ence d<b>Time (years)</b></text>
<text top="152" left="69" width="0" height="9" font="font11" id="p1_t113" reading_order_no="5" segment_no="3" tag_type="figure">(num<b>HI</b></text>
<text top="133" left="69" width="0" height="9" font="font11" id="p1_t114" reading_order_no="4" segment_no="3" tag_type="figure">ber<b>V</b></text>
<text top="115" left="69" width="0" height="14" font="font11" id="p1_t115" reading_order_no="3" segment_no="3" tag_type="figure">fn o<b>inci</b></text>
<text top="106" left="69" width="0" height="9" font="font11" id="p1_t116" reading_order_no="2" segment_no="3" tag_type="figure">ew<b>d</b></text>
<text top="191" left="78" width="0" height="9" font="font11" id="p1_t117" reading_order_no="17" segment_no="3" tag_type="figure">HI<b>ence</b></text>
<text top="184" left="78" width="0" height="9" font="font11" id="p1_t118" reading_order_no="16" segment_no="3" tag_type="figure">V<b>(num</b></text>
<text top="177" left="78" width="0" height="9" font="font11" id="p1_t119" reading_order_no="15" segment_no="3" tag_type="figure">inf<b>ber</b></text>
<text top="168" left="78" width="0" height="9" font="font11" id="p1_t120" reading_order_no="14" segment_no="3" tag_type="figure">ect<b>o</b></text>
<text top="157" left="78" width="0" height="9" font="font11" id="p1_t121" reading_order_no="13" segment_no="3" tag_type="figure">ions<b>fn</b></text>
<text top="139" left="78" width="0" height="9" font="font11" id="p1_t122" reading_order_no="12" segment_no="3" tag_type="figure">per<b>ew</b></text>
<text top="125" left="78" width="0" height="9" font="font11" id="p1_t123" reading_order_no="11" segment_no="3" tag_type="figure">year<b>HI</b></text>
<text top="110" left="78" width="0" height="9" font="font11" id="p1_t124" reading_order_no="10" segment_no="3" tag_type="figure">)<b>V</b></text>
<text top="164" left="176" width="61" height="6" font="font12" id="p1_t125" reading_order_no="35" segment_no="3" tag_type="figure">treatment introduction<b>inf</b></text>
<text top="107" left="239" width="31" height="6" font="font12" id="p1_t126" reading_order_no="30" segment_no="3" tag_type="figure">Scenario A<b>ect</b></text>
<text top="114" left="239" width="31" height="6" font="font12" id="p1_t127" reading_order_no="31" segment_no="3" tag_type="figure">Scenario B<b>ions</b></text>
<text top="122" left="239" width="31" height="6" font="font12" id="p1_t128" reading_order_no="32" segment_no="3" tag_type="figure">Scenario C<b>per</b></text>
<text top="129" left="239" width="31" height="6" font="font12" id="p1_t129" reading_order_no="33" segment_no="3" tag_type="figure">Scenario D<b>year</b></text>
<text top="137" left="239" width="31" height="6" font="font12" id="p1_t130" reading_order_no="34" segment_no="3" tag_type="figure">Scenario E<b>)</b></text>
</page>
</pdf2xml>
